Welcome to Federation Infection Societies Conference 2017

It is our pleasure to invite you to join us in Birmingham for the Federation of Infection Societies (FIS) Annual Conference - Action on Infection 2017. BSAC are delighted to be host organisation for this highlight in the UK infection conferences calendar.

We look forward to delivering an exciting programme that will cover infection prevention and control, existing, new and emerging diagnostics, challenges in treatment and infection management in adult and paediatric medicine, antimicrobial resistance, stewardship, education and measurement of consumption. The challenges in our field are many and multi-disciplinary and the conference programme will deliver education, share expertise and offer insights across plenary, parallel and workshop sessions, in addition to the keynote eponymous lectures by leaders in the field.

CPD points - 19

As in previous years, an application has been made to the Royal College of Pathologists, UK for CME accreditation.

The conference exhibition will offer our partners in industry the opportunity to network and showcase their products, and there will be a new challenge for all at the centre of the exhibition - a must do for all visitors!

The Birmingham International Conference Centre (ICC) is a modern, purpose-built conference facility in the heart of the city and is conveniently located within walking distance of the train station and only 20 minutes from the airport.

We look forward to seeing you in Birmingham

PLEASE NOTE that we have been encountering issues with people using Google Chrome when registering. If you encounter any issues please attempt again using another web browser or contact us below.

Registration Fees

Please note that registration will close at midday this Wednesday 29th November

  Standard Pharmacist / Laboratory staff and Trainees * Nurse Student ** Commercial
Delegate rates
Standard £490 £440 £390 £275 £1500
FIS Society Member £440 £400 £350 £250 N/A
Day registration
One day £220 £180 £150 £100 N/A
Gala dinner
Ticket £45 £45 £45 £45 £45
Group bookings of three or more persons from the same trust qualify for a 20% discount, enter code GROUP17 on check out (note no other discounts apply with this code)
Delegate rates
Standard
Standard £490
Pharmacist / Laboratory staff and Trainees * £440
Nurse £390
Student ** £275
Commercial £1500
FIS Society Member
Standard £440
Pharmacist / Laboratory staff and Trainees * £400
Nurse £350
Student ** £250
Commercial N/A
Day registration
One day
Standard £220
Pharmacist / Laboratory staff and Trainees * £180
Nurse £150
Student ** £100
Commercial N/A
Gala dinner
Ticket
Standard £45
Pharmacist / Laboratory staff and Trainees * £45
Nurse £45
Student ** £45
Commercial £45
Group bookings of three or more persons from the same trust qualify for a 20% discount, enter code GROUP17 on check out (note no other discounts apply with this code)

Please note a further 10% discount is available for all accepted oral or poster presentation abstracts. Please see the registration page for further details. NOTE - this discount does not apply if part of a group booking.

Registration includes scientific session attendance, access to the exhibition, conference materials, welcome reception (full conference or Sunday day delegates only) and daytime catering.

**GOOGLE CHROME** some people have been encountering issues with registration when using Google chrome. Please try using another browser and you can always call the event team who will be happy to assist.

* Trainees include FY1, FY2 and speciality training posts. This fee is not applicable for post graduate positions.

**To qualify for the student rate you must be an undergraduate and you may be asked to verify your status. Those studying for PHDs or working in trainee positions do not qualify for the student rate.

Please note that society discounts do not apply for one day registrations and that group discounts apply to full registrations only.

Any delegate working for Industry / commercial organisations should register using the commercial rate.

Need to contact us?

01353780060 or 07904145899
Andy@pharmatologists.co.uk

Payment can be made online by credit card without any surcharge or by purchase order and invoice. Please provide a valid purchase order number and ensure that your name is quoted on the remittance advice. Please note that payment MUST be received before the event. For PO information please see FAQ's or the information is contained within the registration process.

If you require any assistance with registration please contact Andy using the details above

Programme

Full timings and details will be available shortly on the downloadable programme, including Wound Management, The Challenges of Infections in Burns, Clinical Conundrums, Multi-drug resistant gram negative infections, Faecal Transplants, Antimicrobial Stewardship Quality Indicators, Environmental Decontamination and Water Management, Resistance Surveillance, The challenge of imported mycoses, clinical lessons, free papers, posters and much more ....
0955
Welcome address
Professor Dilip Nathwani OBE

Plenary session: Infection Management Challenges
1000
Whole genome sequencing to inform infection control practice
Dr Nicholas Brown
1030
Streptococcal pneumonia
Dr Wei Shen Lim

1100
COFFEE & POSTER VIEWING

1130
Keynote lecture - The state of AMR globally
Dame Sally Davies, Chief Medical Officer

Concurrent sessions
Wound management
Chair: Dr Nick Brown
Supported by: British Society for Antimicrobial Chemotherapy and the European Wound Management Association
1220
Treating wounds in the face of increasing antimicrobial resistance
Professor Rose Cooper
1250
Using existing non-antibiotic antimicrobial agents effectively in clinical practice
Dr Klaus Kirketerp-Møller
1310
Reactive Oxygen, clinical applications for a novel antimicrobial agent
Dr Matthew Dryden
The conundrum of polymicrobial infection diagnosis: if it’s on the pitch, is it interfering with play?
Chair: Professor Sheila Patrick
Supported by: Microbiology Society
1215
Diabetic foot ulcers: the movers and shakers
Professor Craig Williams
1245
Vaginal discharge: difficulties of diagnosis
Dr Ciara Cox
1315
Retrospective analysis of management of diabetic foot osteomyelitis and its outcome at a tertiary care hospital in the UK
Dr Mauricio Arias
Urosepsis - The fundamentals of prevention
Chair: Professor Heather Loveday
Supported by: Infection Prevention Society
1215
Optimising Hydration - not as easy as it sounds
Professor Jennie Wilson
1245
Natural History of a Urinary Catheter in the Community
Mrs Niki Blackman
1315
To Dip or not to Dip
Ms Elizabeth Beech
Impact of penicillin allergy records on antibiotic prescribing and what "big data" can tell us?
Chair: Professor Robert West
1215
Penicillin allergy - what can big data tell us
Dr Jonathan Sandoe
1240
A general practitioners perspective on penicillin allergy
Dr Haroon Ahmed
1305
Antibiotic allergy in surgical patients - what can be done about it?
Dr Louise Savic

1330
LUNCH & POSTER VIEWING

1415
Barnett Christie Lecture, supported by the British Infection Association - What is the role of biosensors and artificial intelligence in achieving individualised antimicrobial therapy?
Dr Timothy Miles Rawson

Concurrent sessions
Sponsored session 1
Chair: Professor Alasdair MacGowan, Consultant Medical Microbiologist North Bristol NHS Trust
Supported by: Supported by MSD
1500
Join MSD’s expert Faculty in The Microbe Den as they tackle three hot topics for antimicrobial management in secondary care.
Hot Topic #1
Smarter pathogen-based decision making?
Dr Alasdair Hubbard, Research Associate Liverpool School of Tropical Medicine
Hot Topic #2
Earlier use of new antibiotics, why wait?
Dr Sunny Kaul, Consultant Intensivist Royal Brompton and Harefield NHS Foundation Trust
Hot Topic #3
Promoting smarter use of our antibiotic toolbox
Dr Philip Howard, Consultant Antimicrobial Pharmacist Leeds Teaching Hospitals NHS Trust
1545
Summary and conclusion
#4
Dr Howard and Professor MacGowan are not receiving honoraria from MSD for this symposium. A promotional and educational satellite symposium designed for the entire multidisciplinary team, fully funded and organised by MSD. Prescribing Information will be available at the symposium. AINF-1233934-0004 | November 2017
Sponsored session 2
Chair: Dr Varun Mehra, Haemato-oncologist, Kings College Hospital NHS Trust, London
Supported by: Supported by Pfizer
1505
Advancing treatment options for invasive fungal infections
Varun Mehra
1515
A diagnostic-led approach to the management of invasive fungal infections: sharing clinical experience
Dr Silke Schelenz Head Microbiologist, Royal Brompton & Harefield NHS Foundation Trust, London
1540
Panel discussion
Sponsored session 3
Chair: Dr Beryl Oppenheim Senior Director, Medical Affairs, Cepheid
Supported by: Supported by Cepheid
1500
Fighting the challenge of Carbapenemase producing enterobacteriaceae (CPE)
1500
CPE : A Game of Clones - The Liverpool CPE experience
Dr Timothy Neal Infection Control Doctor, Liverpool Clinical Laboratories
1525
Precision medicine: The application of Carbapenemase enzymology to CPE therapy
Dr David Nicolau Director, Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, U.S.A.
1540
Q&A

1545
COFFEE & POSTER VIEWING

Plenary session: The one health agenda: Innovative approaches to stewardship in animal and human health
1615
Innovative approaches to addressing AMR in human health
Professor Dilip Nathwani OBE
1645
Veterinary practice and animal husbandry
Professor Nigel Gibbens, Chief Veterinary Officer
1715
Q&A

Concurrent sessions
Burns Patients and Infection Prevention and Control
Chair: Dr Elizabeth Chipp
Supported by: Healthcare Infection Society
1730
Clinical aspects of infections in burns patients
Dr Elizabeth Chipp
1755
Guidelines on infection control in burns patients
Dr Pauline Jumaa
1820
Outbreaks in burns patients
Dr Mark Garvey & Mr Craig Bradley
Friday afternoon clinical conundrums
Chair: Dr Lim Jones
Supported by: Welsh Microbiology Society
1730
Wound infection-challenges and opportunities in diagnosis and treatment
Professor Keith Harding
1750
“A Wee Problem”
Dr Gavin Forbes
1810
“Gone fishing for a solution.”
Dr Ian Blyth
1830
“Between a rock and a hard place: novel solutions when resistance and renal failure meet.”
Dr Lim Jones & Dr Irasha Hettiarachichi
Debate: The rational for local antibiotic use in surgery to prevent post-operative infection - myth or science?
Chair: Dr Gavin Barlow
Supported by: British Society for Antimicrobial Chemotherapy and European Wound Management Association
1730
Welcome and overview
Dr Gavin Barlow
1740
The use of topical antibiotics for the prevention of surgical site infection: a survey of practice and opinions
Miss Charlotte Cooper & Carolyne Horner
1755
The argument for.....
Professor H Humphreys
1810
The argument against.....
Dr Matthew Dryden
1825
Panel discussion
Invited papers
Chair: Dr Steve Green
Supported by: FIS Conference
1730
Effective treatment guidelines for Pseudomonas aeruginosa bacteraemia
Mr Osman El-Koubani
1745
The impact of reported penicillin allergy on patients presenting with infection
Dr Stephanie Harris
1800
Feasibility of a complex behaviour change intervention in secondary care to safely and substantially reduce antibiotic use.
Dr Elizabeth Cross
1815
Linkage of patient-level antibiotic prescriptions to positive urine microbiology data, England: a pilot study
Dr Berit Muller-Pebody
1830
Candida auris outbreak in a UK intensive care unit driven by multiuse patient monitoring equipment
Dr Katie Jeffery

1930
CONFERENCE DINNER
Clinical lessons
Chair: Dr Katie Jeffery & Dr Hitan Thaker
Supported by: British Infection Association
0800
Spondylodiscitis in an imported Romanian rescue dog - an emerging zoonotic risk to humans
Dr Alessandro Greada
0815
Opportunistic infections: two related cases
Dr Prasun Chakravorty
0830
The clock is TICKing in Europe; cooperation, cross-reaction or co-infection?
Dr Leah Rosenbaum
0845
Imported Gnathostomiasis manifesting as Cutaneous Larva Migrans and Löffler’s syndrome
Dr William Hamilton
Invited papers
Chair: Dr Nick Brown
Supported by: FIS Conference
0800
The impact of the SIGN UTI 2012 guidelines on UTI antibiotic use in secondary care
Mr Neil Powell
0815
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton (UHS)
Dr Julian Sutton
0830
A rare case of invasive amoebiasis requiring emergency subtotal colectomy in an HIV-positive man
Dr Robert Ball
0845
Characterising Post Ebola Syndrome, Sierra Leone 2017:  a summary of project results
Dr Janet Scott

0930
J D Williams Lecture, British Infection Association - "In at the deep end"
Peter Chiodini, Consultant Parasitologist, Hospital for Tropical Diseases, Honorary Professor, London School of Hygiene & Tropical Medicine, Director, Public Health England Malaria Reference Laboratory and PHE National Parasitology Reference Laboratory

1015
COFFEE & POSTER VIEWING

Concurrent sessions
Antimicrobial stewardship quality indicators for hospital and primary care – progress, outcomes and future strategy
Supported by: UKCPA Infection Management Group
1045
Impact of NHS England quality indicators on antimicrobial resistance
Professor Alan Johnson, Head of Department, Public Health England
1115
Quality indicators and outcomes in the devolved nations - Wales
Dr Nicholas Reid, All Wales Consultant Antimicrobial Pharmacist, Public Health Wales
1135
Quality indicators and outcomes in the devolved nations - Scotland
Dr Jacqueline Sneddon, Project Lead SAPG, Healthcare Improvement Scotland
1155
Quality indicators and outcomes in the devolved nations - Northern Ireland
Mrs Cairine Gormley, Chair of the Northern Ireland Antimicrobial Pharmacist Network and Lead Antimicrobial Pharmacist, Altnagelvin Hospital
Multidrug resistance in Bacteroides species: a cause for concern
Supported by: "The Society for Anaerobic Microbiology"
1045
Recent developments in "Bacteroides" Multi-drug resistance
Dr Harriet Hughes
1105
Mechanisms and spread of resistance in "Bacteroides"
Professor Sheila Patrick
1125
TBC
Dr Rohma Ghani
1140
TBC
Dr Ana Soares
1155
Antibiotic Inactivation by Beta-Lactamases to Protect the Gut Microbiome and Attenuate Antibiotic Resistance
Dr Debra Matthews
Paediatric Case Studies: An interactive panel event
Chair: Dr Sanjay Patel & Dr Stephane Paulus
Supported by: British Paediatric Allergy, Immunology & Infection Group
1045
Interactive case presentations
Panelists - Drs Sanjay Patel, Adam Irwin, Stephen Owens, Katja Doerholt, Stephane Paulus & Mitul Patel
Blood borne virus testing
Chair: Dr Andrew Freedman & Dr Erasmus Smit
Supported by: British HIV Association
1045
Is your service compliant with the new NICE standards for HIV Testing 2017?
Dr Steve Taylor
1115
HIV testing in England: how effectively are the NICE guidelines being implemented?
Dr Nicky Connor
1145
London experience with emergency department based testing
Dr Nick Larbalestier

1215
LUNCH & POSTER VIEWING

Sponsored session
Chair: Dr Duncan Wyncoll, Consultant in Intensive Care Medicine, Guy’s and St Thomas’ NHS Foundation Trust
Supported by: Sponsored by Pfizer
1330
Early clinical experience in the use of a beta-lactam/beta-lactamase inhibitor
Dr Jonathan Edgeworth, Consultant Microbiologist, Guy’s and St Thomas’ NHS Foundation Trust, London
1400
Clinical dilemmas in difficult-to-treat infections
Dr Paschalis Vergidis, Consultant in Infectious Diseases, University Hospital of South Manchester, Manchester
1420
Panel discussion

1435
Garrod Lecture - Gram negative infections: Genes, guts and globalisation
Chair Professor Dilip Nathwani with Professor Peter Hawkey, University of Birmingham, Birmingham

1530
COFFEE & POSTER VIEWING

Film screening - CATCH
1600
CATCH - "A story that might so easily be a part of our children's future" - The Lancet infectious diseases

Plenary session: Pandemics and epidemic diseases - where are we now and what next?
Chair: Dr Steve Green
Supported by: British Infection Association and National Travel Health Network and Centre
1615
Global Health Security: Preparedness and Response: Can We Do Better and Stay Safe?
Dr John Watson
1635
Creating an epidemic
Dr Tim Brooks
1655
Epidemics and Pandemics - organising the response at the coal face
Dr Rosamund Southgate
1715
Blood, sweat and tears - using simulation to standardise PPE
Dr Anne Tunbridge

Concurrent sessions
Faecal transplants
Chair: Professor Peter Hawkey
Supported by: Healthcare Infection Society
1745
Faecal transplants - the evidence and experience
Dr Simon Goldenberg
1805
Regulation, accreditation and commercialisation
Dr James McIlroy
1825
Adverse events and unintended consequences
Dr Robert Porter
The Role of In Vitro Diagnostics in Tackling Drug Resistance
Chair: Doris-Ann Williams MBE
Supported by: British In Vitro Diagnostics Association
1745
Health policy development for AMR
Fiona Carragher Deputy Chief Scientific Officer, NHS England
1805
Stimulating novel solutions for AMR by competition
Caroline Purslow, programme manager, Longitude Prize
1825
Developments in the industry for AMR
Doris-Ann Williams
Weird and imported mycoses
Chair: Professor Tom Rogers
Supported by: British Society for Medical Mycology
1745
Some weird and wonderful fungal infections
Dr Elizabeth Johnson
1805
Candida auris
Dr Silke Schlenz
1825
Unusual mould infections
Dr Alida Fe Talento
Offered papers
Supported by: FIS Conference
1745
Infections in multi-visceral transplant patients; a two year study
Mr Ronak Shah & Bogdan Petrisor
1800
Renal failure and active tuberculosis in a high incidence UK city
1815
Scottish Reduction in Antimicrobial Prescribing (ScRAP) Programme: Update and feedback on a national Primary Care Educational Resource
Dr Jacqueline Sneddon
1830
A National Survey to evaluate perceptions about achieving a national quality incentive scheme to reduce antibiotic use in hospitals
Dr Jasmin Islam

Clinical lessons - clinical infection prevention and control
Chair: Dr Elisabeth Ridgway
Supported by: Healthcare Infection Society
0745
Acquisition and Transmission Networks of Enterococcus faecium Revealed by Whole Genome Sequencing: a Longitudinal Cohort Study
0800
Aerosolisation and dispersal of Carbapenemase-producing Enterobacteriaceae from hospital waste traps: a laboratory study.
Dr Ginny Moore
0815
The impact of observational hand hygiene auditing on consultant doctors hand hygiene behaviour. A qualitative study.
Ms Maura Smiddy
0830
Which interventions are most fruitful in controlling endemic C. difficile infections in gastroenterology patients including a ribotype 027 outbreak?
Ms Emma Hughes
Invited Papers
Supported by: FIS Conference
0745
Stethoscope Hygiene - Why the double standard?
Dr Kirsten Herregods
0800
Modelling the transmission and prevention of Hepatitis B Virus (HBV) infection: can we meet sustainable development goals for elimination by 2030?
Dr Philippa Matthews
0815
Are children at increased risk of severe influenza receiving seasonal influenza vaccine? An audit of practice at Alder Hey Children's Hospital.
Miss Caitlin Lythgoe & Madeleine Baxter
0830
Mortality is associated with dysregulated host inflammation in the CSF compartment of Malawian adults with pneumococcal meningitis
Dr Emma Wall

0900
Lowbury Lecture, Healthcare Infection Society - Make Economics Your Friend
Professor Nick Graves, Professor of Health Economics at Institute of Biomedical and Health Innovation, School of Public Health, Queensland University of Technology Queensland Health, Australia

Sponsored sessions
Sponsored session 1
Supported by: Supported by European Tissue Symposium
1000
Drying hands matters - is the risk worthwhile?
Professor Mark Wilcox
Sponsored session 2
Chair: Dr Damian Mack & Steve Holland
Supported by: Supported by Accelerate Diagnostics
1000
Technology overview
Steve Holland, Managing Director, Accelerate Diagnostics
1015
Case study 1
Dr Damien Mack Consultant Microbiologist, Royal Free London Hospital NHS Foundation Trust
1030
Case Study 2
Dr Nicki Hutchinson, Medical Director and Consultant Microbiologist, Hampshire Hospitals NHS Foundation Trust

1045
COFFEE & POSTER VIEWING

Concurrent sessions
NITCAR: Bigger is better-the National Infection Trainee Collaborative
Supported by: NITCAR
1115
HOODINI: A multicentre point prevalence study of Hospital onset diarrhoea
Dr Damian Mawer
1130
National HCV Audit: Follow up of serologically proven HCV infection
Miss Leila White
1145
CABI: A multicentre study of complicated intra-abdominal infection management and outcomes
Dr Shadia Ahmed
1200
NITCAR: Planning for the future
Dr Jordan Skittrall
How to...........
Supported by: BSAC & BIA
1115
Maintain the pipeline and attract junior doctors to train in your specialty  
Dr Steve Green
1135
Organise an effective and entertaining academic meeting  
Dr Nick Brown
1155
How best to engage with non-infection specialists that have a responsibility for antimicrobial use
Dr Bridget Atkins
Healthcare water management
Supported by: Healthcare Infection Society
1115
What does a DIPC / ICD want from a water safety committee?
Dr Mike Weinbren
1140
Water services new builds and refurbishments
Dr Mary Ashcroft
1205
HTM 04-01 revisited
Dr Mark Garvey

Film screening - CATCH
1215
CATCH - "A story that might so easily be a part of our children's future" - The Lancet infectious diseases

Creative innovative informatics and surveillance
Supported by: British Society for Antimicrobial Chemotherapy
1230
Improved surveillance of bugs and drugs that includes patient data
Dr Susan Hopkins
1300
Informatics to support clinical decision making
Dr Charis Marwick

1330
Closing remarks
Philip Howard BSAC Vice President

1330
LUNCH will be available from the foyer

1300
HIS AGM

1330
HIS Lowbury Lunch (by invitation only)

1415
CONFERENCE CLOSES

Location

Broad Street, Birmingham,
+44 (0) 121 644 5025
info@theicc.co.uk

Sponsors

Latest Twitter

  • Thank you to all who attended - looking forward to welcoming you to and our regional OPAT workshops in the Spring!,
  • Great visual representation of Europe’s battle against antimicrobial resistance ,
  • RT : Tim Hills talks about @BSACandJAC’s Drug Stability Programme - & what its findings might mean for the OPAT arena… ,
  • ‘Public Health England marketing director: Our challenges are huge, but I have great hope’ via @prweek,
Top